Global Medical Antifungal Agent Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Page: 111

Published Date: 05 Sep 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Medical Antifungal Agent market size was valued at USD 13400 million in 2022 and is forecast to a readjusted size of USD 16240 million by 2029 with a CAGR of 2.8% during review period.

Antifungals are medicines that kill or stop the growth of fungi that cause infections.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

The Global Info Research report includes an overview of the development of the Medical Antifungal Agent industry chain, the market status of Dermatophytosis (Azoles, Echinocandins), Aspergillosis (Azoles, Echinocandins), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Medical Antifungal Agent.

Regionally, the report analyzes the Medical Antifungal Agent markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Medical Antifungal Agent market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Medical Antifungal Agent market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Medical Antifungal Agent industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Azoles, Echinocandins).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Medical Antifungal Agent market.

Regional Analysis: The report involves examining the Medical Antifungal Agent market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Medical Antifungal Agent market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Medical Antifungal Agent:
Company Analysis: Report covers individual Medical Antifungal Agent manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Medical Antifungal Agent This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Dermatophytosis, Aspergillosis).

Technology Analysis: Report covers specific technologies relevant to Medical Antifungal Agent. It assesses the current state, advancements, and potential future developments in Medical Antifungal Agent areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Medical Antifungal Agent market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Medical Antifungal Agent market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
Azoles
Echinocandins
Polyenes
Allylamines
Others

Market segment by Application
Dermatophytosis
Aspergillosis
Candidiasis
Others

Major players covered
Novartis
Pfizer
Bayer
Sanofi
Merck & Co
GlaxoSmithKline
MSD Manuals
Abbott
Glenmark
Enzon Pharmaceuticals
Astellas Pharma
Scynexis
Cidara Therapeutics
Lucigen Corporation
Biosergen
F2G
Sichuan Meidakang Pharmaceutical
Chengdu Taihe Health Technology

Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Medical Antifungal Agent product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Medical Antifungal Agent, with price, sales, revenue and global market share of Medical Antifungal Agent from 2018 to 2023.
Chapter 3, the Medical Antifungal Agent competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Medical Antifungal Agent breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Medical Antifungal Agent market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Medical Antifungal Agent.
Chapter 14 and 15, to describe Medical Antifungal Agent sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Medical Antifungal Agent
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Medical Antifungal Agent Consumption Value by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Azoles
        1.3.3 Echinocandins
        1.3.4 Polyenes
        1.3.5 Allylamines
        1.3.6 Others
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Medical Antifungal Agent Consumption Value by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Dermatophytosis
        1.4.3 Aspergillosis
        1.4.4 Candidiasis
        1.4.5 Others
    1.5 Global Medical Antifungal Agent Market Size & Forecast
        1.5.1 Global Medical Antifungal Agent Consumption Value (2018 & 2022 & 2029)
        1.5.2 Global Medical Antifungal Agent Sales Quantity (2018-2029)
        1.5.3 Global Medical Antifungal Agent Average Price (2018-2029)

2 Manufacturers Profiles
    2.1 Novartis
        2.1.1 Novartis Details
        2.1.2 Novartis Major Business
        2.1.3 Novartis Medical Antifungal Agent Product and Services
        2.1.4 Novartis Medical Antifungal Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Novartis Recent Developments/Updates
    2.2 Pfizer
        2.2.1 Pfizer Details
        2.2.2 Pfizer Major Business
        2.2.3 Pfizer Medical Antifungal Agent Product and Services
        2.2.4 Pfizer Medical Antifungal Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Pfizer Recent Developments/Updates
    2.3 Bayer
        2.3.1 Bayer Details
        2.3.2 Bayer Major Business
        2.3.3 Bayer Medical Antifungal Agent Product and Services
        2.3.4 Bayer Medical Antifungal Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Bayer Recent Developments/Updates
    2.4 Sanofi
        2.4.1 Sanofi Details
        2.4.2 Sanofi Major Business
        2.4.3 Sanofi Medical Antifungal Agent Product and Services
        2.4.4 Sanofi Medical Antifungal Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Sanofi Recent Developments/Updates
    2.5 Merck & Co
        2.5.1 Merck & Co Details
        2.5.2 Merck & Co Major Business
        2.5.3 Merck & Co Medical Antifungal Agent Product and Services
        2.5.4 Merck & Co Medical Antifungal Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Merck & Co Recent Developments/Updates
    2.6 GlaxoSmithKline
        2.6.1 GlaxoSmithKline Details
        2.6.2 GlaxoSmithKline Major Business
        2.6.3 GlaxoSmithKline Medical Antifungal Agent Product and Services
        2.6.4 GlaxoSmithKline Medical Antifungal Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 GlaxoSmithKline Recent Developments/Updates
    2.7 MSD Manuals
        2.7.1 MSD Manuals Details
        2.7.2 MSD Manuals Major Business
        2.7.3 MSD Manuals Medical Antifungal Agent Product and Services
        2.7.4 MSD Manuals Medical Antifungal Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 MSD Manuals Recent Developments/Updates
    2.8 Abbott
        2.8.1 Abbott Details
        2.8.2 Abbott Major Business
        2.8.3 Abbott Medical Antifungal Agent Product and Services
        2.8.4 Abbott Medical Antifungal Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Abbott Recent Developments/Updates
    2.9 Glenmark
        2.9.1 Glenmark Details
        2.9.2 Glenmark Major Business
        2.9.3 Glenmark Medical Antifungal Agent Product and Services
        2.9.4 Glenmark Medical Antifungal Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Glenmark Recent Developments/Updates
    2.10 Enzon Pharmaceuticals
        2.10.1 Enzon Pharmaceuticals Details
        2.10.2 Enzon Pharmaceuticals Major Business
        2.10.3 Enzon Pharmaceuticals Medical Antifungal Agent Product and Services
        2.10.4 Enzon Pharmaceuticals Medical Antifungal Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Enzon Pharmaceuticals Recent Developments/Updates
    2.11 Astellas Pharma
        2.11.1 Astellas Pharma Details
        2.11.2 Astellas Pharma Major Business
        2.11.3 Astellas Pharma Medical Antifungal Agent Product and Services
        2.11.4 Astellas Pharma Medical Antifungal Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 Astellas Pharma Recent Developments/Updates
    2.12 Scynexis
        2.12.1 Scynexis Details
        2.12.2 Scynexis Major Business
        2.12.3 Scynexis Medical Antifungal Agent Product and Services
        2.12.4 Scynexis Medical Antifungal Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.12.5 Scynexis Recent Developments/Updates
    2.13 Cidara Therapeutics
        2.13.1 Cidara Therapeutics Details
        2.13.2 Cidara Therapeutics Major Business
        2.13.3 Cidara Therapeutics Medical Antifungal Agent Product and Services
        2.13.4 Cidara Therapeutics Medical Antifungal Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.13.5 Cidara Therapeutics Recent Developments/Updates
    2.14 Lucigen Corporation
        2.14.1 Lucigen Corporation Details
        2.14.2 Lucigen Corporation Major Business
        2.14.3 Lucigen Corporation Medical Antifungal Agent Product and Services
        2.14.4 Lucigen Corporation Medical Antifungal Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.14.5 Lucigen Corporation Recent Developments/Updates
    2.15 Biosergen
        2.15.1 Biosergen Details
        2.15.2 Biosergen Major Business
        2.15.3 Biosergen Medical Antifungal Agent Product and Services
        2.15.4 Biosergen Medical Antifungal Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.15.5 Biosergen Recent Developments/Updates
    2.16 F2G
        2.16.1 F2G Details
        2.16.2 F2G Major Business
        2.16.3 F2G Medical Antifungal Agent Product and Services
        2.16.4 F2G Medical Antifungal Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.16.5 F2G Recent Developments/Updates
    2.17 Sichuan Meidakang Pharmaceutical
        2.17.1 Sichuan Meidakang Pharmaceutical Details
        2.17.2 Sichuan Meidakang Pharmaceutical Major Business
        2.17.3 Sichuan Meidakang Pharmaceutical Medical Antifungal Agent Product and Services
        2.17.4 Sichuan Meidakang Pharmaceutical Medical Antifungal Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.17.5 Sichuan Meidakang Pharmaceutical Recent Developments/Updates
    2.18 Chengdu Taihe Health Technology
        2.18.1 Chengdu Taihe Health Technology Details
        2.18.2 Chengdu Taihe Health Technology Major Business
        2.18.3 Chengdu Taihe Health Technology Medical Antifungal Agent Product and Services
        2.18.4 Chengdu Taihe Health Technology Medical Antifungal Agent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.18.5 Chengdu Taihe Health Technology Recent Developments/Updates

3 Competitive Environment: Medical Antifungal Agent by Manufacturer
    3.1 Global Medical Antifungal Agent Sales Quantity by Manufacturer (2018-2023)
    3.2 Global Medical Antifungal Agent Revenue by Manufacturer (2018-2023)
    3.3 Global Medical Antifungal Agent Average Price by Manufacturer (2018-2023)
    3.4 Market Share Analysis (2022)
        3.4.1 Producer Shipments of Medical Antifungal Agent by Manufacturer Revenue ($MM) and Market Share (%): 2022
        3.4.2 Top 3 Medical Antifungal Agent Manufacturer Market Share in 2022
        3.4.2 Top 6 Medical Antifungal Agent Manufacturer Market Share in 2022
    3.5 Medical Antifungal Agent Market: Overall Company Footprint Analysis
        3.5.1 Medical Antifungal Agent Market: Region Footprint
        3.5.2 Medical Antifungal Agent Market: Company Product Type Footprint
        3.5.3 Medical Antifungal Agent Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Medical Antifungal Agent Market Size by Region
        4.1.1 Global Medical Antifungal Agent Sales Quantity by Region (2018-2029)
        4.1.2 Global Medical Antifungal Agent Consumption Value by Region (2018-2029)
        4.1.3 Global Medical Antifungal Agent Average Price by Region (2018-2029)
    4.2 North America Medical Antifungal Agent Consumption Value (2018-2029)
    4.3 Europe Medical Antifungal Agent Consumption Value (2018-2029)
    4.4 Asia-Pacific Medical Antifungal Agent Consumption Value (2018-2029)
    4.5 South America Medical Antifungal Agent Consumption Value (2018-2029)
    4.6 Middle East and Africa Medical Antifungal Agent Consumption Value (2018-2029)

5 Market Segment by Type
    5.1 Global Medical Antifungal Agent Sales Quantity by Type (2018-2029)
    5.2 Global Medical Antifungal Agent Consumption Value by Type (2018-2029)
    5.3 Global Medical Antifungal Agent Average Price by Type (2018-2029)

6 Market Segment by Application
    6.1 Global Medical Antifungal Agent Sales Quantity by Application (2018-2029)
    6.2 Global Medical Antifungal Agent Consumption Value by Application (2018-2029)
    6.3 Global Medical Antifungal Agent Average Price by Application (2018-2029)

7 North America
    7.1 North America Medical Antifungal Agent Sales Quantity by Type (2018-2029)
    7.2 North America Medical Antifungal Agent Sales Quantity by Application (2018-2029)
    7.3 North America Medical Antifungal Agent Market Size by Country
        7.3.1 North America Medical Antifungal Agent Sales Quantity by Country (2018-2029)
        7.3.2 North America Medical Antifungal Agent Consumption Value by Country (2018-2029)
        7.3.3 United States Market Size and Forecast (2018-2029)
        7.3.4 Canada Market Size and Forecast (2018-2029)
        7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
    8.1 Europe Medical Antifungal Agent Sales Quantity by Type (2018-2029)
    8.2 Europe Medical Antifungal Agent Sales Quantity by Application (2018-2029)
    8.3 Europe Medical Antifungal Agent Market Size by Country
        8.3.1 Europe Medical Antifungal Agent Sales Quantity by Country (2018-2029)
        8.3.2 Europe Medical Antifungal Agent Consumption Value by Country (2018-2029)
        8.3.3 Germany Market Size and Forecast (2018-2029)
        8.3.4 France Market Size and Forecast (2018-2029)
        8.3.5 United Kingdom Market Size and Forecast (2018-2029)
        8.3.6 Russia Market Size and Forecast (2018-2029)
        8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
    9.1 Asia-Pacific Medical Antifungal Agent Sales Quantity by Type (2018-2029)
    9.2 Asia-Pacific Medical Antifungal Agent Sales Quantity by Application (2018-2029)
    9.3 Asia-Pacific Medical Antifungal Agent Market Size by Region
        9.3.1 Asia-Pacific Medical Antifungal Agent Sales Quantity by Region (2018-2029)
        9.3.2 Asia-Pacific Medical Antifungal Agent Consumption Value by Region (2018-2029)
        9.3.3 China Market Size and Forecast (2018-2029)
        9.3.4 Japan Market Size and Forecast (2018-2029)
        9.3.5 Korea Market Size and Forecast (2018-2029)
        9.3.6 India Market Size and Forecast (2018-2029)
        9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
        9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
    10.1 South America Medical Antifungal Agent Sales Quantity by Type (2018-2029)
    10.2 South America Medical Antifungal Agent Sales Quantity by Application (2018-2029)
    10.3 South America Medical Antifungal Agent Market Size by Country
        10.3.1 South America Medical Antifungal Agent Sales Quantity by Country (2018-2029)
        10.3.2 South America Medical Antifungal Agent Consumption Value by Country (2018-2029)
        10.3.3 Brazil Market Size and Forecast (2018-2029)
        10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
    11.1 Middle East & Africa Medical Antifungal Agent Sales Quantity by Type (2018-2029)
    11.2 Middle East & Africa Medical Antifungal Agent Sales Quantity by Application (2018-2029)
    11.3 Middle East & Africa Medical Antifungal Agent Market Size by Country
        11.3.1 Middle East & Africa Medical Antifungal Agent Sales Quantity by Country (2018-2029)
        11.3.2 Middle East & Africa Medical Antifungal Agent Consumption Value by Country (2018-2029)
        11.3.3 Turkey Market Size and Forecast (2018-2029)
        11.3.4 Egypt Market Size and Forecast (2018-2029)
        11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
        11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
    12.1 Medical Antifungal Agent Market Drivers
    12.2 Medical Antifungal Agent Market Restraints
    12.3 Medical Antifungal Agent Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
    13.1 Raw Material of Medical Antifungal Agent and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Medical Antifungal Agent
    13.3 Medical Antifungal Agent Production Process
    13.4 Medical Antifungal Agent Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Medical Antifungal Agent Typical Distributors
    14.3 Medical Antifungal Agent Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Medical Antifungal Agent Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Medical Antifungal Agent Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Novartis Basic Information, Manufacturing Base and Competitors
    Table 4. Novartis Major Business
    Table 5. Novartis Medical Antifungal Agent Product and Services
    Table 6. Novartis Medical Antifungal Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 7. Novartis Recent Developments/Updates
    Table 8. Pfizer Basic Information, Manufacturing Base and Competitors
    Table 9. Pfizer Major Business
    Table 10. Pfizer Medical Antifungal Agent Product and Services
    Table 11. Pfizer Medical Antifungal Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 12. Pfizer Recent Developments/Updates
    Table 13. Bayer Basic Information, Manufacturing Base and Competitors
    Table 14. Bayer Major Business
    Table 15. Bayer Medical Antifungal Agent Product and Services
    Table 16. Bayer Medical Antifungal Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 17. Bayer Recent Developments/Updates
    Table 18. Sanofi Basic Information, Manufacturing Base and Competitors
    Table 19. Sanofi Major Business
    Table 20. Sanofi Medical Antifungal Agent Product and Services
    Table 21. Sanofi Medical Antifungal Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 22. Sanofi Recent Developments/Updates
    Table 23. Merck & Co Basic Information, Manufacturing Base and Competitors
    Table 24. Merck & Co Major Business
    Table 25. Merck & Co Medical Antifungal Agent Product and Services
    Table 26. Merck & Co Medical Antifungal Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 27. Merck & Co Recent Developments/Updates
    Table 28. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
    Table 29. GlaxoSmithKline Major Business
    Table 30. GlaxoSmithKline Medical Antifungal Agent Product and Services
    Table 31. GlaxoSmithKline Medical Antifungal Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 32. GlaxoSmithKline Recent Developments/Updates
    Table 33. MSD Manuals Basic Information, Manufacturing Base and Competitors
    Table 34. MSD Manuals Major Business
    Table 35. MSD Manuals Medical Antifungal Agent Product and Services
    Table 36. MSD Manuals Medical Antifungal Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 37. MSD Manuals Recent Developments/Updates
    Table 38. Abbott Basic Information, Manufacturing Base and Competitors
    Table 39. Abbott Major Business
    Table 40. Abbott Medical Antifungal Agent Product and Services
    Table 41. Abbott Medical Antifungal Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 42. Abbott Recent Developments/Updates
    Table 43. Glenmark Basic Information, Manufacturing Base and Competitors
    Table 44. Glenmark Major Business
    Table 45. Glenmark Medical Antifungal Agent Product and Services
    Table 46. Glenmark Medical Antifungal Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 47. Glenmark Recent Developments/Updates
    Table 48. Enzon Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 49. Enzon Pharmaceuticals Major Business
    Table 50. Enzon Pharmaceuticals Medical Antifungal Agent Product and Services
    Table 51. Enzon Pharmaceuticals Medical Antifungal Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 52. Enzon Pharmaceuticals Recent Developments/Updates
    Table 53. Astellas Pharma Basic Information, Manufacturing Base and Competitors
    Table 54. Astellas Pharma Major Business
    Table 55. Astellas Pharma Medical Antifungal Agent Product and Services
    Table 56. Astellas Pharma Medical Antifungal Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 57. Astellas Pharma Recent Developments/Updates
    Table 58. Scynexis Basic Information, Manufacturing Base and Competitors
    Table 59. Scynexis Major Business
    Table 60. Scynexis Medical Antifungal Agent Product and Services
    Table 61. Scynexis Medical Antifungal Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 62. Scynexis Recent Developments/Updates
    Table 63. Cidara Therapeutics Basic Information, Manufacturing Base and Competitors
    Table 64. Cidara Therapeutics Major Business
    Table 65. Cidara Therapeutics Medical Antifungal Agent Product and Services
    Table 66. Cidara Therapeutics Medical Antifungal Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 67. Cidara Therapeutics Recent Developments/Updates
    Table 68. Lucigen Corporation Basic Information, Manufacturing Base and Competitors
    Table 69. Lucigen Corporation Major Business
    Table 70. Lucigen Corporation Medical Antifungal Agent Product and Services
    Table 71. Lucigen Corporation Medical Antifungal Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 72. Lucigen Corporation Recent Developments/Updates
    Table 73. Biosergen Basic Information, Manufacturing Base and Competitors
    Table 74. Biosergen Major Business
    Table 75. Biosergen Medical Antifungal Agent Product and Services
    Table 76. Biosergen Medical Antifungal Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 77. Biosergen Recent Developments/Updates
    Table 78. F2G Basic Information, Manufacturing Base and Competitors
    Table 79. F2G Major Business
    Table 80. F2G Medical Antifungal Agent Product and Services
    Table 81. F2G Medical Antifungal Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 82. F2G Recent Developments/Updates
    Table 83. Sichuan Meidakang Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 84. Sichuan Meidakang Pharmaceutical Major Business
    Table 85. Sichuan Meidakang Pharmaceutical Medical Antifungal Agent Product and Services
    Table 86. Sichuan Meidakang Pharmaceutical Medical Antifungal Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 87. Sichuan Meidakang Pharmaceutical Recent Developments/Updates
    Table 88. Chengdu Taihe Health Technology Basic Information, Manufacturing Base and Competitors
    Table 89. Chengdu Taihe Health Technology Major Business
    Table 90. Chengdu Taihe Health Technology Medical Antifungal Agent Product and Services
    Table 91. Chengdu Taihe Health Technology Medical Antifungal Agent Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 92. Chengdu Taihe Health Technology Recent Developments/Updates
    Table 93. Global Medical Antifungal Agent Sales Quantity by Manufacturer (2018-2023) & (K Units)
    Table 94. Global Medical Antifungal Agent Revenue by Manufacturer (2018-2023) & (USD Million)
    Table 95. Global Medical Antifungal Agent Average Price by Manufacturer (2018-2023) & (US$/Unit)
    Table 96. Market Position of Manufacturers in Medical Antifungal Agent, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
    Table 97. Head Office and Medical Antifungal Agent Production Site of Key Manufacturer
    Table 98. Medical Antifungal Agent Market: Company Product Type Footprint
    Table 99. Medical Antifungal Agent Market: Company Product Application Footprint
    Table 100. Medical Antifungal Agent New Market Entrants and Barriers to Market Entry
    Table 101. Medical Antifungal Agent Mergers, Acquisition, Agreements, and Collaborations
    Table 102. Global Medical Antifungal Agent Sales Quantity by Region (2018-2023) & (K Units)
    Table 103. Global Medical Antifungal Agent Sales Quantity by Region (2024-2029) & (K Units)
    Table 104. Global Medical Antifungal Agent Consumption Value by Region (2018-2023) & (USD Million)
    Table 105. Global Medical Antifungal Agent Consumption Value by Region (2024-2029) & (USD Million)
    Table 106. Global Medical Antifungal Agent Average Price by Region (2018-2023) & (US$/Unit)
    Table 107. Global Medical Antifungal Agent Average Price by Region (2024-2029) & (US$/Unit)
    Table 108. Global Medical Antifungal Agent Sales Quantity by Type (2018-2023) & (K Units)
    Table 109. Global Medical Antifungal Agent Sales Quantity by Type (2024-2029) & (K Units)
    Table 110. Global Medical Antifungal Agent Consumption Value by Type (2018-2023) & (USD Million)
    Table 111. Global Medical Antifungal Agent Consumption Value by Type (2024-2029) & (USD Million)
    Table 112. Global Medical Antifungal Agent Average Price by Type (2018-2023) & (US$/Unit)
    Table 113. Global Medical Antifungal Agent Average Price by Type (2024-2029) & (US$/Unit)
    Table 114. Global Medical Antifungal Agent Sales Quantity by Application (2018-2023) & (K Units)
    Table 115. Global Medical Antifungal Agent Sales Quantity by Application (2024-2029) & (K Units)
    Table 116. Global Medical Antifungal Agent Consumption Value by Application (2018-2023) & (USD Million)
    Table 117. Global Medical Antifungal Agent Consumption Value by Application (2024-2029) & (USD Million)
    Table 118. Global Medical Antifungal Agent Average Price by Application (2018-2023) & (US$/Unit)
    Table 119. Global Medical Antifungal Agent Average Price by Application (2024-2029) & (US$/Unit)
    Table 120. North America Medical Antifungal Agent Sales Quantity by Type (2018-2023) & (K Units)
    Table 121. North America Medical Antifungal Agent Sales Quantity by Type (2024-2029) & (K Units)
    Table 122. North America Medical Antifungal Agent Sales Quantity by Application (2018-2023) & (K Units)
    Table 123. North America Medical Antifungal Agent Sales Quantity by Application (2024-2029) & (K Units)
    Table 124. North America Medical Antifungal Agent Sales Quantity by Country (2018-2023) & (K Units)
    Table 125. North America Medical Antifungal Agent Sales Quantity by Country (2024-2029) & (K Units)
    Table 126. North America Medical Antifungal Agent Consumption Value by Country (2018-2023) & (USD Million)
    Table 127. North America Medical Antifungal Agent Consumption Value by Country (2024-2029) & (USD Million)
    Table 128. Europe Medical Antifungal Agent Sales Quantity by Type (2018-2023) & (K Units)
    Table 129. Europe Medical Antifungal Agent Sales Quantity by Type (2024-2029) & (K Units)
    Table 130. Europe Medical Antifungal Agent Sales Quantity by Application (2018-2023) & (K Units)
    Table 131. Europe Medical Antifungal Agent Sales Quantity by Application (2024-2029) & (K Units)
    Table 132. Europe Medical Antifungal Agent Sales Quantity by Country (2018-2023) & (K Units)
    Table 133. Europe Medical Antifungal Agent Sales Quantity by Country (2024-2029) & (K Units)
    Table 134. Europe Medical Antifungal Agent Consumption Value by Country (2018-2023) & (USD Million)
    Table 135. Europe Medical Antifungal Agent Consumption Value by Country (2024-2029) & (USD Million)
    Table 136. Asia-Pacific Medical Antifungal Agent Sales Quantity by Type (2018-2023) & (K Units)
    Table 137. Asia-Pacific Medical Antifungal Agent Sales Quantity by Type (2024-2029) & (K Units)
    Table 138. Asia-Pacific Medical Antifungal Agent Sales Quantity by Application (2018-2023) & (K Units)
    Table 139. Asia-Pacific Medical Antifungal Agent Sales Quantity by Application (2024-2029) & (K Units)
    Table 140. Asia-Pacific Medical Antifungal Agent Sales Quantity by Region (2018-2023) & (K Units)
    Table 141. Asia-Pacific Medical Antifungal Agent Sales Quantity by Region (2024-2029) & (K Units)
    Table 142. Asia-Pacific Medical Antifungal Agent Consumption Value by Region (2018-2023) & (USD Million)
    Table 143. Asia-Pacific Medical Antifungal Agent Consumption Value by Region (2024-2029) & (USD Million)
    Table 144. South America Medical Antifungal Agent Sales Quantity by Type (2018-2023) & (K Units)
    Table 145. South America Medical Antifungal Agent Sales Quantity by Type (2024-2029) & (K Units)
    Table 146. South America Medical Antifungal Agent Sales Quantity by Application (2018-2023) & (K Units)
    Table 147. South America Medical Antifungal Agent Sales Quantity by Application (2024-2029) & (K Units)
    Table 148. South America Medical Antifungal Agent Sales Quantity by Country (2018-2023) & (K Units)
    Table 149. South America Medical Antifungal Agent Sales Quantity by Country (2024-2029) & (K Units)
    Table 150. South America Medical Antifungal Agent Consumption Value by Country (2018-2023) & (USD Million)
    Table 151. South America Medical Antifungal Agent Consumption Value by Country (2024-2029) & (USD Million)
    Table 152. Middle East & Africa Medical Antifungal Agent Sales Quantity by Type (2018-2023) & (K Units)
    Table 153. Middle East & Africa Medical Antifungal Agent Sales Quantity by Type (2024-2029) & (K Units)
    Table 154. Middle East & Africa Medical Antifungal Agent Sales Quantity by Application (2018-2023) & (K Units)
    Table 155. Middle East & Africa Medical Antifungal Agent Sales Quantity by Application (2024-2029) & (K Units)
    Table 156. Middle East & Africa Medical Antifungal Agent Sales Quantity by Region (2018-2023) & (K Units)
    Table 157. Middle East & Africa Medical Antifungal Agent Sales Quantity by Region (2024-2029) & (K Units)
    Table 158. Middle East & Africa Medical Antifungal Agent Consumption Value by Region (2018-2023) & (USD Million)
    Table 159. Middle East & Africa Medical Antifungal Agent Consumption Value by Region (2024-2029) & (USD Million)
    Table 160. Medical Antifungal Agent Raw Material
    Table 161. Key Manufacturers of Medical Antifungal Agent Raw Materials
    Table 162. Medical Antifungal Agent Typical Distributors
    Table 163. Medical Antifungal Agent Typical Customers
List of Figures
    Figure 1. Medical Antifungal Agent Picture
    Figure 2. Global Medical Antifungal Agent Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Medical Antifungal Agent Consumption Value Market Share by Type in 2022
    Figure 4. Azoles Examples
    Figure 5. Echinocandins Examples
    Figure 6. Polyenes Examples
    Figure 7. Allylamines Examples
    Figure 8. Others Examples
    Figure 9. Global Medical Antifungal Agent Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 10. Global Medical Antifungal Agent Consumption Value Market Share by Application in 2022
    Figure 11. Dermatophytosis Examples
    Figure 12. Aspergillosis Examples
    Figure 13. Candidiasis Examples
    Figure 14. Others Examples
    Figure 15. Global Medical Antifungal Agent Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 16. Global Medical Antifungal Agent Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 17. Global Medical Antifungal Agent Sales Quantity (2018-2029) & (K Units)
    Figure 18. Global Medical Antifungal Agent Average Price (2018-2029) & (US$/Unit)
    Figure 19. Global Medical Antifungal Agent Sales Quantity Market Share by Manufacturer in 2022
    Figure 20. Global Medical Antifungal Agent Consumption Value Market Share by Manufacturer in 2022
    Figure 21. Producer Shipments of Medical Antifungal Agent by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
    Figure 22. Top 3 Medical Antifungal Agent Manufacturer (Consumption Value) Market Share in 2022
    Figure 23. Top 6 Medical Antifungal Agent Manufacturer (Consumption Value) Market Share in 2022
    Figure 24. Global Medical Antifungal Agent Sales Quantity Market Share by Region (2018-2029)
    Figure 25. Global Medical Antifungal Agent Consumption Value Market Share by Region (2018-2029)
    Figure 26. North America Medical Antifungal Agent Consumption Value (2018-2029) & (USD Million)
    Figure 27. Europe Medical Antifungal Agent Consumption Value (2018-2029) & (USD Million)
    Figure 28. Asia-Pacific Medical Antifungal Agent Consumption Value (2018-2029) & (USD Million)
    Figure 29. South America Medical Antifungal Agent Consumption Value (2018-2029) & (USD Million)
    Figure 30. Middle East & Africa Medical Antifungal Agent Consumption Value (2018-2029) & (USD Million)
    Figure 31. Global Medical Antifungal Agent Sales Quantity Market Share by Type (2018-2029)
    Figure 32. Global Medical Antifungal Agent Consumption Value Market Share by Type (2018-2029)
    Figure 33. Global Medical Antifungal Agent Average Price by Type (2018-2029) & (US$/Unit)
    Figure 34. Global Medical Antifungal Agent Sales Quantity Market Share by Application (2018-2029)
    Figure 35. Global Medical Antifungal Agent Consumption Value Market Share by Application (2018-2029)
    Figure 36. Global Medical Antifungal Agent Average Price by Application (2018-2029) & (US$/Unit)
    Figure 37. North America Medical Antifungal Agent Sales Quantity Market Share by Type (2018-2029)
    Figure 38. North America Medical Antifungal Agent Sales Quantity Market Share by Application (2018-2029)
    Figure 39. North America Medical Antifungal Agent Sales Quantity Market Share by Country (2018-2029)
    Figure 40. North America Medical Antifungal Agent Consumption Value Market Share by Country (2018-2029)
    Figure 41. United States Medical Antifungal Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 42. Canada Medical Antifungal Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 43. Mexico Medical Antifungal Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 44. Europe Medical Antifungal Agent Sales Quantity Market Share by Type (2018-2029)
    Figure 45. Europe Medical Antifungal Agent Sales Quantity Market Share by Application (2018-2029)
    Figure 46. Europe Medical Antifungal Agent Sales Quantity Market Share by Country (2018-2029)
    Figure 47. Europe Medical Antifungal Agent Consumption Value Market Share by Country (2018-2029)
    Figure 48. Germany Medical Antifungal Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 49. France Medical Antifungal Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 50. United Kingdom Medical Antifungal Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 51. Russia Medical Antifungal Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 52. Italy Medical Antifungal Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 53. Asia-Pacific Medical Antifungal Agent Sales Quantity Market Share by Type (2018-2029)
    Figure 54. Asia-Pacific Medical Antifungal Agent Sales Quantity Market Share by Application (2018-2029)
    Figure 55. Asia-Pacific Medical Antifungal Agent Sales Quantity Market Share by Region (2018-2029)
    Figure 56. Asia-Pacific Medical Antifungal Agent Consumption Value Market Share by Region (2018-2029)
    Figure 57. China Medical Antifungal Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 58. Japan Medical Antifungal Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 59. Korea Medical Antifungal Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 60. India Medical Antifungal Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 61. Southeast Asia Medical Antifungal Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 62. Australia Medical Antifungal Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 63. South America Medical Antifungal Agent Sales Quantity Market Share by Type (2018-2029)
    Figure 64. South America Medical Antifungal Agent Sales Quantity Market Share by Application (2018-2029)
    Figure 65. South America Medical Antifungal Agent Sales Quantity Market Share by Country (2018-2029)
    Figure 66. South America Medical Antifungal Agent Consumption Value Market Share by Country (2018-2029)
    Figure 67. Brazil Medical Antifungal Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 68. Argentina Medical Antifungal Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 69. Middle East & Africa Medical Antifungal Agent Sales Quantity Market Share by Type (2018-2029)
    Figure 70. Middle East & Africa Medical Antifungal Agent Sales Quantity Market Share by Application (2018-2029)
    Figure 71. Middle East & Africa Medical Antifungal Agent Sales Quantity Market Share by Region (2018-2029)
    Figure 72. Middle East & Africa Medical Antifungal Agent Consumption Value Market Share by Region (2018-2029)
    Figure 73. Turkey Medical Antifungal Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 74. Egypt Medical Antifungal Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 75. Saudi Arabia Medical Antifungal Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 76. South Africa Medical Antifungal Agent Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 77. Medical Antifungal Agent Market Drivers
    Figure 78. Medical Antifungal Agent Market Restraints
    Figure 79. Medical Antifungal Agent Market Trends
    Figure 80. Porters Five Forces Analysis
    Figure 81. Manufacturing Cost Structure Analysis of Medical Antifungal Agent in 2022
    Figure 82. Manufacturing Process Analysis of Medical Antifungal Agent
    Figure 83. Medical Antifungal Agent Industrial Chain
    Figure 84. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 85. Direct Channel Pros & Cons
    Figure 86. Indirect Channel Pros & Cons
    Figure 87. Methodology
    Figure 88. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Novartis
Pfizer
Bayer
Sanofi
Merck & Co
GlaxoSmithKline
MSD Manuals
Abbott
Glenmark
Enzon Pharmaceuticals
Astellas Pharma
Scynexis
Cidara Therapeutics
Lucigen Corporation
Biosergen
F2G
Sichuan Meidakang Pharmaceutical
Chengdu Taihe Health Technology

Related Reports

Global Medical Antifungal Agent Supply, Demand and Key Producers, 2023-2029

Global Medical Antifungal Agent Supply, Demand and Key Producers, 2023-2029

date 05 Sep 2023

date Pharma & Healthcare

The global Medical Antifungal Agent market size is expected to reach $ 16240 million by 2029, rising at a market growth of 2.8% CAGR during the forecast period (2023-2029).

Global Medical Antifungal Agent Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Medical Antifungal Agent Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 14 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Medical Antifungal Agent market size was valued at USD 13400 million in 2023 and is forecast to a readjusted size of USD 16240 million by 2030 with a CAGR of 2.8% during review period.

Product Tags

Medical Antifungal Agent

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>